Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Extreme Manual for Picking a Camper Van - 2How does Spotify Wrapped calculate your listening age? What your number says about you.
- 3FDA official discusses potential link between COVID-19 vaccines and pediatric deaths
- 4A photographer finds thousands of dinosaur footprints near Italian Winter Olympic venue
- 5Vote in favor of Your #1 4\u00d74 SUVs
- Experience Is standing by: 10 Pleasant Setting up camp Areas to
- Hunger and makeshift shelters persist in north Caribbean nearly 2 months after Hurricane Melissa
- Taste the World: Five Food sources That Have Dazzled Worldwide Palates
- Vote in favor of your Favored Travel Movement
- 6 Hints to Upgrade Your Appeal, In addition to Your Outlook
- What causes RFK Jr.’s strained and shaky voice? A neurologist explains this little-known disorder
- Creative Style: 10 Architects Reclassifying the Business
- Portable Installment Answers for Independent ventures
- The Way to Monetary Freedom: A Viable Aide
